Amplitude Ventures is a full-stack Canadian venture capital firm based in Montreal that creates, builds, and grows precision medicine companies at the intersection of biology and AI. The firm invests across therapeutics, medical technologies, and healthcare IT from ideation through patient care.
76% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Average disclosed round size is $59.1M (across 28 rounds with reported amounts).
Portfolio
23
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Dion Madsen
Managing Partner
Allison Gaw
Partner
Juliana Muñoz Escobar
Associate
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
34 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Congruence Therapeutics | Series B | $39.5M | Mar 2026 |
 Mediar | Series B | $76M | Jan 2026 |
| Congruence Therapeutics | Unknown | $32M | Sep 2025 |
 FLUID BIOMED | Series A | $27M | Dec 2024 |
 Evommune | Series C | $115M | Oct 2024 |
 Ability Biologics | Seed | $18M | Jun 2024 |
 Nomic Bio | Series B | $42M | Jan 2024 |
| FLUID BIOMED | Series A | $27M | Jan 2024 |
 Nomic Bio | Series B | $42M | Jan 2024 |
| Evommune | Series B | $50M | Apr 2023 |
 Abdera Therapeutics Inc. | Series A | $142M | Apr 2023 |
| AAbdera | Series B | $110M | Apr 2023 |
| Congruence Therapeutics | Series A | $65M | Mar 2023 |
 Abdera Therapeutics | Series B | $110M | Jan 2023 |
 Drugbank | Seed | — | Apr 2022 |
| CCelsius Therapeutics | Series A | $63M | Mar 2022 |
| CCelsius Therapeutics | Series B | $83M | Mar 2022 |
| Congruence Therapeutics | Series A | $50M | Feb 2022 |
 Gandeeva Therapeutics | Series A | $40M | Jan 2022 |
 Thryv Therapeutics | Series A | $19M | Aug 2021 |
 Notch Therapeutics | Series A | $85M | Feb 2021 |
| Abdera Therapeutics | Series A | $32.5M | Jan 2021 |
| AAbdera | Series A | $32.5M | Jan 2021 |
| Abdera Therapeutics Inc. | Series A | — | Jan 2021 |
 Deep Genomics | Series C | $180M | Jan 2021 |
Page 1 of 2
Top Co-Investors
Versant Ventures8 shared
Alexandria Venture Investments7 shared
Fonds de solidarité FTQ5 shared
Casdin Capital5 shared
Viking Global Investors5 shared
adMare BioInnovations5 shared
OrbiMed4 shared
Longwood Fund3 shared
Investissement Québec3 shared
Illumina Ventures3 shared
venBio3 shared
Qiming Venture Partners USA3 shared
Amgen Ventures3 shared
Lux Capital3 shared
Andera Partners2 shared
EQT Life Sciences2 shared
SymBiosis2 shared
Pivotal Life Sciences2 shared
RA Capital Management2 shared
Sofinnova Partners2 shared
Last updated: 20 October 2026